Evidence map›Paper›PMID 27228368›Full record

ArticleThe Journal of clinical endocrinology and metabolism2016

Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome.

Jaye Adams, Zhilin Liu, Yi Athena Ren, Wan-Song Wun, Wei Zhou, Shlomit Kenigsberg, Clifford Librach, Cecilia Valdes, William Gibbons, JoAnne Richards

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The effects ofResearch in pharmaceutical sciences · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Polycystic Ovarian Syndrome: A Review of Multi-omics Analyses.Reproductive sciences (Thousand Oaks, Calif.) · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jaye AdamsDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
Zhilin LiuDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
Yi Athena RenDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
Wan-Song WunDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
Wei ZhouDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
Shlomit KenigsbergDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
Clifford LibrachDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
Cecilia ValdesDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
William GibbonsDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
JoAnne RichardsDepartment of Molecular and Cellular Biology (J.A., Z.L., Y.A.R., J.R.) and Division of Reproductive Endocrinology and Infertility (J.A., C.V., W.G.), Baylor College of Medicine, and M. D. Anderson Cancer Center (W.Z.), Houston, Texas 77030; Fertility Specialists of Houston (Z.L., W.-S.W.), Houston, Texas; 77030 and CReATe Fertility Center (S.K., C.L.), Toronto, Canada M5G 1N8.
CReATe Fertility Centre · CAHouston Fertility Institute · USThe University of Texas MD Anderson Cancer Center · US

Funding

TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI DEMAYO, FRANCESCO JOHN · 1998 to 2013
$19.9M
PROJECT 3 - Steroid-Metabolic Interactions In the Control of GnRH NeuronsU54HD028934 · NICHD · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI MARSHALL, JOHN C · 1998 to 2013
$16.5M
Testosterone-GnRH Frequency and the Evolution of PCOS in AdolescenceP50HD028934 · NICHD · UNIVERSITY OF VIRGINIA · PI HAISENLEDER, DANIEL J. · 2014 to 2018
$8.6M
LH ACTION IN OVARIAN CELL DIFFERENTIATIONR37HD016229 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE S. · 1998 to 2007
$2.0M
LH ACTION IN OVARIAN CELL DIFFERENTIATIONR01HD016229 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 1985 to 2013
$1.9M
Mechanisms Controlling Divergent Fates of Ovarian Follicles and FertilityR01HD076980 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 2014 to 2018
$1.9M
Steroid Hormones Regulate Ovarian Cancer Progression and MetastasisR01CA181808 · NCI · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 2014 to 2018
$1.7M
GROWTH AND DIFFERENTIATION IN EUKARYOTEST32HD007495 · NICHD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI KINTNER, CHRISTOPHER ROBERT · 1995 to 2009
$1.6M
LH Action in Ovarian Cell DifferentiationR56HD016229 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 2008 to 2008
$326k
TRANSGENIC ANIMAL--COREP30HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI GLASSER, STANLEY R · 1985 to 1997
–
NCI NIH HHS R01 CA181808NICHD NIH HHS P30 HD007495NICHD NIH HHS P50 HD028934NICHD NIH HHS R01 HD016229NICHD NIH HHS R01 HD076980NICHD NIH HHS R37 HD016229NICHD NIH HHS R56 HD016229NICHD NIH HHS T32 HD007495NICHD NIH HHS U54 HD007495NICHD NIH HHS U54 HD028934
6 · The paper itself

Abstract

contextPolycystic ovarian syndrome (PCOS), the most common endocrine disorder of reproductive-aged women, is associated with systemic low-grade inflammation.

objectiveWe propose that increased or altered intrafollicular inflammatory reactions also occur in periovulatory follicles of PCOS patients.

designGene profiling and quantitative PCR (qPCR) analyses in granulosa-lutein cells (GCs) collected from PCOS and non-PCOS women undergoing in vitro fertilization were compared with serum and follicular fluid (FF) levels of cytokines and chemokines.

settingThis was a university-based study. PATIENTS: Twenty-one PCOS and 45 control patients were recruited: demographic, hormone, body mass index, and pregnancy outcomes were abstracted from patient data files.

interventionsGC cytokine/chemokine mRNAs were identified and analyzed by gene-chip microarrays/qPCR before and after culture with human chorionic gonadotropin, DHT, IL-6, or IL-8; serum/FF cytokine levels were also analyzed.

main outcome measuresRelative serum/FF cytokine levels and GC cytokine expression before and after culture were compared and related to body mass index.

resultsThe following results were found: 1) PCOS GCs express elevated transcripts encoding cytokines, chemokines, and immune cell markers, 2) based on gene profiling and qPCR analyses, obese PCOS patients define a distinct PCOS disease subtype with the most dramatic increases in proinflammatory and immune-related factors, and 3) human chorionic gonadotropin and DHT increased cytokine production in cultured GCs, whereas cytokines augmented cytokine and vascular genes, indicating that hyperandrogenism/elevated LH and obesity in PCOS women augment intrafollicular cytokine production.

conclusionsIntrafollicular androgens and cytokines likely comprise a local regulatory loop that impacts GC expression of cytokines and chemokines and the presence of immune cells; this loop is further enhanced in the obese PCOS subtype.

Indexed as

AdultBiomarkersCase-Control StudiesCells, CulturedChemokinesCytokinesFemaleFertilization in VitroFollicular FluidFollow-Up StudiesGene Expression ProfilingHumansInflammationLuteal CellsPolycystic Ovary SyndromePregnancyBiomarkersChemokinesCytokinesRNA, Messenger

Identifiers

PMID27228368
PMCPMC5010574
OpenAlexW2396164820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.